135 related articles for article (PubMed ID: 10773967)
1. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control.
Diaz-Borjon A; Richaud-Patin Y; Alvarado de la Barrera C; Jakez-Ocampo J; Ruiz-Argüelles A; Llorente L
Joint Bone Spine; 2000 Jan; 67(1):40-8. PubMed ID: 10773967
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome.
Llorente L; Richaud-Patin Y; Díaz-Borjón A; Alvarado de la Barrera C; Jakez-Ocampo J; de la Fuente H; Gonzalez-Amaro R; Diaz-Jouanen E
Joint Bone Spine; 2000 Jan; 67(1):30-9. PubMed ID: 10773966
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance-1 (MDR-1) in autoimmune disorders III: increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients.
Ruiz-Soto R; Richaud-Patin Y; López-Karpovitch X; Llorente L
Exp Hematol; 2003 Jun; 31(6):483-7. PubMed ID: 12829023
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients.
Richaud-Patin Y; Vega-Boada F; Vidaller A; Llorente L
Biomed Pharmacother; 2004 Jun; 58(5):320-4. PubMed ID: 15194168
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease.
Tsujimura S; Tanaka Y
Clin Exp Nephrol; 2012 Feb; 16(1):102-8. PubMed ID: 21847519
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus.
Tsujimura S; Saito K; Nakayamada S; Nakano K; Tanaka Y
Arthritis Rheum; 2005 Jun; 52(6):1676-83. PubMed ID: 15934077
[TBL] [Abstract][Full Text] [Related]
7. [Multi-drug resistance in the treatments of autoimmune diseases].
Tanaka Y; Tsujimura S
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Oct; 29(5):319-24. PubMed ID: 17075191
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein-1 functional activity in CD5+CD7+ and CD20+ lymphocytes in systemic lupus erythematosus children: relation to disease activity, complications and steroid response.
Ragab SM; Soliman MA
Egypt J Immunol; 2013; 20(2):101-15. PubMed ID: 24617050
[TBL] [Abstract][Full Text] [Related]
10. [Multidrug resistance: a century after "606"].
Llorente L; Richaud-Patin Y; Jakez-Ocampo J
Rev Invest Clin; 2001; 53(5):444-51. PubMed ID: 11795110
[No Abstract] [Full Text] [Related]
11. Validation of a single point flow cytometric assay for determining P-glycoprotein activity in multidrug resistant cell lines.
Chin-Yee I; Crowther MA; Keeney M; Wright L; Daly S
Clin Lab Haematol; 1994 Sep; 16(3):261-72. PubMed ID: 7828413
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
Yano S; Sone S; Nishioka Y; Naito M; Tsuruo T; Ogura T
Jpn J Cancer Res; 1994 Feb; 85(2):194-203. PubMed ID: 7511575
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein functions in peripheral-blood CD4+ cells of patients with systemic lupus erythematosus.
Henmi K; Yoshida M; Yoshikawa N; Hirano T
Biol Pharm Bull; 2008 May; 31(5):873-8. PubMed ID: 18451510
[TBL] [Abstract][Full Text] [Related]
14. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.
Farrell RJ; Murphy A; Long A; Donnelly S; Cherikuri A; O'Toole D; Mahmud N; Keeling PW; Weir DG; Kelleher D
Gastroenterology; 2000 Feb; 118(2):279-88. PubMed ID: 10648456
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of P-glycoprotein activity on peripheral blood mononuclear cells and polymorphonuclear neutrophils to methotrexate in systemic lupus erythematosus patients.
García-Carrasco M; Mendoza-Pinto C; Macías-Díaz S; Etchegaray-Morales I; Méndez-Martínez S; Soto-Santillán P; Pérez-Romano B; Jiménez-Herrera EA; Guzmán-Ruiz O; Ruiz-Argüelles A
Clin Rheumatol; 2017 Oct; 36(10):2267-2272. PubMed ID: 28616661
[TBL] [Abstract][Full Text] [Related]
16. Persistent expression and function of P-glycoprotein on peripheral blood lymphocytes identifies corticosteroid resistance in patients with systemic lupus erythematosus.
Kansal A; Tripathi D; Rai MK; Agarwal V
Clin Rheumatol; 2016 Feb; 35(2):341-9. PubMed ID: 26415739
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein in autoimmune diseases.
Richaud-Patin Y; Soto-Vega E; Jakez-Ocampo J; Llorente L
Autoimmun Rev; 2004 Mar; 3(3):188-92. PubMed ID: 15110230
[TBL] [Abstract][Full Text] [Related]
18. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
[TBL] [Abstract][Full Text] [Related]
19. In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.
Baines P; Limaye M; Hoy T; Padua RA; Whittaker J; al-Sabah A; Burnett A
Leuk Res; 1994 Sep; 18(9):683-91. PubMed ID: 7934144
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
